J.P. Morgan Reiterates Overweight Rating On Allscripts Healthcare Solutions

According to J.P. Morgan, Allscripts Healthcare Solutions MDRX Overweight rating is reiterated. J.P. Morgan said that 1Q EPS and revenue was ahead of consensus, and cash flow was also ahead of expectations. “On the other hand, bookings were weaker than we expected, largely due to the fact that we and the Street did not model a difficult y/y comparison faced by the company. On looking deeper at the bookings trend, we are less concerned than we were in our initial read, and maintain our positive outlook.” Allscripts Healthcare Solutions closed yesterday at $21.31.